SC

Strategy Canon

Veradigm (Allscripts): sourced choices

6 product and go-to-market choices, oldest first. Back to the case study

  1. 2022-03-02Product · Disposed products Hospital and large-practice assets included Sunrise, Paragon and TouchWorks. VE1
  2. 2022-03-02Go_To_Market · Portfolio sale Allscripts announced a fixed $670 million price plus contingent consideration for the disposed assets. VE1
  3. 2024-02-28Go_To_Market · Listing compliance Delayed required filings led to trading suspension. VE2
  4. 2025-03-28Product · Retained products Veradigm retained ambulatory software and data offerings. VE3
  5. 2025-03-28Product · Restatement Previously reported financial results required restatement. VE3
  6. 2026-05-26Go_To_Market · Later disclosure The company filed a consolidated annual report for multiple years. VE4